Multiple Myeloma in General Practice A Guide to Diagnosis and Management
This article is written on behalf of the Medical and Scientific Advisory Group, Myeloma Australia.
Multiple myeloma (MM) is a clinically aggressive blood cancer, most frequently diagnosed in late adulthood, and requires prompt assessment and treatment to avoid irreversible organ damage. The finding of monoclonal protein on serum or urine testing is a hallmark feature of MM, and other laboratory investigations are readily available to help establish the diagnosis. Patient outcomes are improving because of an expanding range of therapies that produce meaningful improvements in survival and quality of life. Care needs for patients with multiple myeloma can be complex and are best met with a multidisciplinary approach based on shared care between the GP and specialist haematologist.
Modern Medicine – Issue 3, 2025
